MECDUO Trademark

Trademark Overview


On Friday, September 18, 2020, a trademark application was filed for MECDUO with the United States Patent and Trademark Office. The USPTO has given the MECDUO trademark a serial number of 90191681. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Wednesday, March 9, 2022. This trademark is owned by Pfizer Inc.. The MECDUO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; Pharmaceutical preparations for the treatment of atopic dermatitis, eczema, psoriasis, lupus, inflammatory bowel disease, crohn's disease, ulcerative colitis, psoriatic arthritis, alopecia areata, vitiligo, and hidradenitis suppurativa
mecduo

General Information


Serial Number90191681
Word MarkMECDUO
Filing DateFriday, September 18, 2020
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateWednesday, March 9, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 16, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; Pharmaceutical preparations for the treatment of atopic dermatitis, eczema, psoriasis, lupus, inflammatory bowel disease, crohn's disease, ulcerative colitis, psoriatic arthritis, alopecia areata, vitiligo, and hidradenitis suppurativa

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateWednesday, March 9, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Wednesday, March 9, 2022ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Wednesday, March 9, 2022ABANDONMENT - AFTER PUBLICATION
Tuesday, March 8, 2022TEAS EXPRESS ABANDONMENT RECEIVED
Wednesday, September 1, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 30, 2021EXTENSION 1 GRANTED
Monday, August 30, 2021EXTENSION 1 FILED
Monday, August 30, 2021TEAS EXTENSION RECEIVED
Tuesday, April 13, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 16, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 16, 2021PUBLISHED FOR OPPOSITION
Wednesday, January 27, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 12, 2021ASSIGNED TO EXAMINER
Wednesday, October 28, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 22, 2020NEW APPLICATION ENTERED IN TRAM